Atossa Genetics Inc (ATOS) — Cash Flow-to-Debt Ratio
Atossa Genetics Inc (ATOS) has a Cash Flow-to-Debt Ratio of -0.73x as of September 2025, meaning its operating cash flow of $-6.00 Million could theoretically repay -1% of its total liabilities ($8.22 Million) in one year. Explore how much of Atossa Genetics Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Atossa Genetics Inc Cash Flow-to-Debt Ratio (2009–2024)
Historical debt coverage capacity for Atossa Genetics Inc across 16 annual periods. Also explore total assets of Atossa Genetics Inc for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Atossa Genetics Inc (2009–2024)
Year-by-year debt coverage analysis for Atossa Genetics Inc. For market capitalisation and broader financial context, see Atossa Genetics Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -4.23x | $-21.03 Million | $4.97 Million | ▼ -5.9% |
| 2023 | -4.00x | $-20.94 Million | $5.24 Million | ▼ -7.3% |
| 2022 | -3.73x | $-20.76 Million | $5.57 Million | ▲ +29.2% |
| 2021 | -5.27x | $-16.47 Million | $3.13 Million | ▼ -613.9% |
| 2020 | -0.74x | $-11.57 Million | $15.68 Million | ▲ +89.1% |
| 2019 | -6.79x | $-9.13 Million | $1.34 Million | ▼ -120.9% |
| 2018 | -3.07x | $-8.96 Million | $2.92 Million | ▲ +42.9% |
| 2017 | -5.38x | $-6.59 Million | $1.23 Million | ▼ -4.9% |
| 2016 | -5.13x | $-5.37 Million | $1.05 Million | ▲ +8.0% |
| 2015 | -5.58x | $-13.95 Million | $2.50 Million | ▼ -19.7% |
| 2014 | -4.66x | $-10.56 Million | $2.27 Million | ▲ +25.8% |
| 2013 | -6.27x | $-8.83 Million | $1.41 Million | ▼ -165.5% |
| 2012 | -2.36x | $-3.90 Million | $1.65 Million | ▼ -2.3% |
| 2011 | -2.31x | $-3.49 Million | $1.51 Million | ▼ -459.0% |
| 2010 | -0.41x | $-358.11K | $866.86K | ▲ +70.4% |
| 2009 | -1.40x | $-75.18K | $53.78K | — |